Startseite>>Labeling & Detection>> Fluorescence>>IR 783

IR 783

Katalog-Nr.GC48378

A fluorescent probe for in vivo tumor cell imaging

Products are for research use only. Not for human use. We do not sell to patients.

IR 783 Chemische Struktur

Cas No.: 115970-66-6

Größe Preis Lagerbestand Menge
50mg
39,00 $
Auf Lager
100mg
63,00 $
Auf Lager
250mg
98,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

IR 783 is a heptamethine cyanine fluorescent probe for in vivo imaging of tumor cells.1,2 It displays excitation/emission maxima of 633/780 nm, respectively. IR 783 is transported into tumor cells, an effect that can be blocked by the organic anion transporting polypeptide (OATP) inhibitor sulfobromophthalein .1 In vivo, IR 783 (11.25 mg/kg) preferentially accumulates in tumor tissue in an ACHN kidney cancer mouse xenograft model.2 It has been conjugated to polyethylenimines for tumor-specific gene delivery.3

1.Yuan, J., Yi, X., Yan, F., et al.Near?infrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyesMol. Med. Rep.11(2)821-828(2015) 2.Yang, X., Shao, C., Wang, R., et al.Optical imaging of kidney cancer with novel near-infrared heptamethine carbocyanine fluorescent dyesJ. Urol.189(2)702-710(2013) 3.De Los Reyes-Berbel, E., Salto-Gonzalez, R., Ortega-MuÑoz, M., et al.PEI-NIR heptamethine cyanine nanotheranostics for tumor targeted gene deliveryBioconjug. Chem.29(8)2561-2575(2018)

Bewertungen

Review for IR 783

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for IR 783

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.